MYOV
Myovant Sciences Ltd.
MYOV
MYOV
Delisted
MYOV was delisted on the 9th of March, 2023.
52 hedge funds and large institutions have $621M invested in Myovant Sciences Ltd. in 2016 Q4 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
QF
1
QVT Financial
New York
|
$463M |
| 2 |
BB
2
BB Biotech
Schaffhausen,
Switzerland
|
$39.7M |
| 3 |
RCM
3
RA Capital Management
Boston,
Massachusetts
|
$18.7M |
| 4 |
DM
4
Deerfield Management
New York
|
$18.6M |
| 5 |
SCM
5
Scopia Capital Management
New York
|
$10.2M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $2K | +$2K | +200 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $1K | +$1K | +100 | New |
|